Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Revolution Medicines Inc (RVMD)

Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,167,177
  • Shares Outstanding, K 164,986
  • Annual Sales, $ 11,580 K
  • Annual Income, $ -436,370 K
  • 60-Month Beta 1.46
  • Price/Sales 529.58
  • Price/Cash Flow N/A
  • Price/Book 3.68
Trade RVMD with:

Options Overview Details

View History
  • Implied Volatility 78.94% ( -1.48%)
  • Historical Volatility 48.00%
  • IV Percentile 83%
  • IV Rank 25.88%
  • IV High 176.22% on 10/20/23
  • IV Low 44.97% on 08/15/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 764
  • Volume Avg (30-Day) 391
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 16,138
  • Open Int (30-Day) 14,738

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.75
  • Number of Estimates 9
  • High Estimate -0.73
  • Low Estimate -0.77
  • Prior Year -0.92
  • Growth Rate Est. (year over year) +18.48%

Price Performance

See More
Period Period Low Period High Performance
1-Month
34.23 +15.07%
on 04/19/24
40.21 -2.04%
on 05/03/24
+3.85 (+10.83%)
since 04/15/24
3-Month
28.43 +38.55%
on 02/21/24
40.21 -2.04%
on 05/03/24
+9.91 (+33.62%)
since 02/15/24
52-Week
15.44 +155.11%
on 10/23/23
40.21 -2.04%
on 05/03/24
+12.85 (+48.42%)
since 05/15/23

Most Recent Stories

More News
Stocks Retreat as Bond Yields Surge on US Price Pressures

The S&P 500 Index ($SPX ) (SPY ) Wednesday closed down -0.95%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -1.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.87%. Stock indexes...

$SPX : 5,308.15 (+1.17%)
SPY : 529.78 (+1.24%)
$DOWI : 39,908.00 (+0.88%)
DIA : 399.28 (+0.94%)
$IUXX : 18,596.65 (+1.49%)
QQQ : 452.90 (+1.56%)
ZNM24 : 109-250 (+0.06%)
DECK : 903.68 (+2.41%)
DHI : 157.58 (+6.47%)
BLDR : 171.94 (+1.31%)
LEN : 170.85 (+5.25%)
PHM : 122.07 (+5.07%)
Stocks Tumble as Sticky US CPI Curbs the Outlook for Fed Rate Cuts

The S&P 500 Index ($SPX ) (SPY ) this morning is down -0.95%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.13%. Stock indexes today...

$SPX : 5,308.15 (+1.17%)
SPY : 529.78 (+1.24%)
$DOWI : 39,908.00 (+0.88%)
DIA : 399.28 (+0.94%)
$IUXX : 18,596.65 (+1.49%)
QQQ : 452.90 (+1.56%)
ZNM24 : 109-250 (+0.06%)
DECK : 903.68 (+2.41%)
DHI : 157.58 (+6.47%)
BLDR : 171.94 (+1.31%)
TOL : 134.92 (+5.92%)
LEN : 170.85 (+5.25%)
Stocks Sink as US CPI Tops Forecasts

The S&P 500 Index ($SPX ) (SPY ) this morning is down -1.01%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.20%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.00%. Stock indexes today...

$SPX : 5,308.15 (+1.17%)
SPY : 529.78 (+1.24%)
$DOWI : 39,908.00 (+0.88%)
DIA : 399.28 (+0.94%)
$IUXX : 18,596.65 (+1.49%)
QQQ : 452.90 (+1.56%)
ZNM24 : 109-250 (+0.06%)
DECK : 903.68 (+2.41%)
DHI : 157.58 (+6.47%)
BLDR : 171.94 (+1.31%)
TOL : 134.92 (+5.92%)
LEN : 170.85 (+5.25%)
Why Revolution Medicines Stock Is Crashing Today

Investors were disappointed by Revolution Medicines' data, presented at ESMO.

RVMD : 39.39 (+5.38%)
Why Shares of Revolution Medicines Were Popping on Friday

The company released positive phase 1/1b trial data on two cancer therapies.

RVMD : 39.39 (+5.38%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RETA, EQRX, RVMD

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

RETA : 172.36 (+0.02%)
EQRX : 2.34 (-2.09%)
RVMD : 39.39 (+5.38%)
Revolution Medicines, Inc. (RVMD) Reports Q1 Loss, Tops Revenue Estimates

Revolution Medicines, Inc. (RVMD) delivered earnings and revenue surprises of 14.29% and 68.36%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

RVMD : 39.39 (+5.38%)
IPSC : 3.09 (-1.90%)
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Tops Revenue Estimates

Crinetics Pharmaceuticals, Inc. (CRNX) delivered earnings and revenue surprises of -3.66% and 325.24%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the...

CRNX : 50.49 (+2.25%)
RVMD : 39.39 (+5.38%)
AcelRx Pharmaceuticals (ACRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

AcelRx Pharmaceuticals (ACRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ACRX : 0.8600 (+7.50%)
RVMD : 39.39 (+5.38%)
Wall Street Analysts Think Revolution Medicines, Inc. (RVMD) Could Surge 27.24%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 27.2% in Revolution Medicines, Inc. (RVMD). While the effectiveness of this highly sought-after metric is questionable,...

RVMD : 39.39 (+5.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Revolution Medicines Inc. is a clinical-stage oncology company. It is focused on developing targeted therapies to inhibit elusive frontier targets within notorious cancer pathways. Revolution Medicines Inc. is based in CA, United States.

See More

Key Turning Points

3rd Resistance Point 42.04
2nd Resistance Point 40.98
1st Resistance Point 40.19
Last Price 39.39
1st Support Level 38.34
2nd Support Level 37.28
3rd Support Level 36.49

See More

52-Week High 40.21
Last Price 39.39
Fibonacci 61.8% 30.75
Fibonacci 50% 27.83
Fibonacci 38.2% 24.90
52-Week Low 15.44

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar